GSK Total Assets 2010-2023 | GSK
GSK total assets from 2010 to 2023. Total assets can be defined as the sum of all assets on a company's balance sheet.
- GSK total assets for the quarter ending March 31, 2023 were $71.182B, a 40.85% decline year-over-year.
- GSK total assets for 2022 were $74.395B, a 31.61% decline from 2021.
- GSK total assets for 2021 were $108.775B, a 5.33% increase from 2020.
- GSK total assets for 2020 were $103.273B, a 1.49% increase from 2019.
GSK Annual Total Assets
(Millions of US $) |
| 2022 |
$74,395 |
| 2021 |
$108,775 |
| 2020 |
$103,273 |
| 2019 |
$101,759 |
| 2018 |
$77,507 |
| 2017 |
$72,664 |
| 2016 |
$80,072 |
| 2015 |
$81,719 |
| 2014 |
$66,997 |
| 2013 |
$65,856 |
| 2012 |
$65,742 |
| 2011 |
$65,909 |
| 2010 |
$65,025 |
| 2009 |
$67,118 |
GSK Quarterly Total Assets
(Millions of US $) |
| 2023-03-31 |
$71,182 |
| 2022-12-31 |
$74,395 |
| 2022-09-30 |
$71,037 |
| 2022-06-30 |
$111,796 |
| 2022-03-31 |
$120,345 |
| 2021-12-31 |
$108,775 |
| 2021-09-30 |
$108,504 |
| 2021-06-30 |
$107,646 |
| 2021-03-31 |
$107,671 |
| 2020-12-31 |
$103,273 |
| 2020-09-30 |
$104,542 |
| 2020-06-30 |
$105,030 |
| 2020-03-31 |
$108,093 |
| 2019-12-31 |
$101,759 |
| 2019-09-30 |
$102,649 |
| 2019-06-30 |
$81,812 |
| 2019-03-31 |
$81,230 |
| 2018-12-31 |
$77,507 |
| 2018-09-30 |
$76,361 |
| 2018-06-30 |
$78,441 |
| 2018-03-31 |
$78,151 |
| 2017-12-31 |
$72,664 |
| 2017-09-30 |
$76,959 |
| 2017-06-30 |
$74,468 |
| 2017-03-31 |
$73,374 |
| 2016-09-30 |
$77,205 |
| 2016-06-30 |
$82,689 |
| 2016-03-31 |
$78,058 |
| 2015-12-31 |
$81,719 |
| 2015-09-30 |
$82,363 |
| 2015-06-30 |
$82,887 |
| 2015-03-31 |
$87,928 |
| 2014-12-31 |
$66,997 |
| 2014-09-30 |
$67,346 |
| 2014-06-30 |
$65,385 |
| 2014-03-31 |
$65,723 |
| 2013-12-31 |
$65,856 |
| 2013-09-30 |
$63,721 |
| 2013-06-30 |
$64,611 |
| 2013-03-31 |
$66,641 |
| 2012-12-31 |
$65,742 |
| 2012-09-30 |
$63,912 |
| 2012-06-30 |
$67,235 |
| 2012-03-31 |
$64,100 |
| 2011-12-31 |
$65,909 |
| 2011-09-30 |
$66,753 |
| 2011-06-30 |
$68,671 |
| 2011-03-31 |
$68,167 |
| 2010-12-31 |
$65,025 |
| 2010-09-30 |
$66,096 |
| 2010-06-30 |
$64,231 |
| 2010-03-31 |
$69,571 |
| 2009-12-31 |
$67,118 |
| 2009-09-30 |
$68,039 |
| 2009-06-30 |
$55,675 |
| 2009-03-31 |
$56,322 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Biomedical and Genetics |
$70.187B |
$36.279B |
|
GSK plc is a biopharma company. Its vaccine portfolio protects people from meningitis, shingles, flu, polio, measles and many more. GSK plc, formerly known as GLAXOSMITHKLINE, is based in Brentford, the United Kingdom.
|
